George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Krafty have a look after 3.00 on the daily chart, I would say 80% odd in a volume now 2.9m.
Isn"t it amazing how many people were available to read that news and react accordingly?
We are just now 1 point short of the previous high since Redmile bought in.
Morning All, was it ever a contentious issue that Scancell kept control of the data. Not in my mind, it is their data and the more we have discussed it would it even be legally binding that a patient could not share their personal experiences to anyone they choose.
It is paramount that a cancer patient and/or loved ones can talk abut their feelings
So, there are just 3 trading weeks left until Xmas, from the information we have there is a great chance of news in that time, here"s to an outstanding close to the year
TF......"Scouse it must be you that's suffering from 'wild speculation and panic' and confusion - to me it seems like the BB has been quietly looking at what's going on. That's all."""
How you can say "quietly" is beyond me!!! There was nothing quiet about last Sunday when as ever you incited and prolonged a big disagreement again with myself and AB. Every post you have to agree or disagree with and decide what is right or wrong, but you never add your own opinion to any discussion. Between you and another there were 30 odd posts, I posted twice all day, until late in the evening, the same subject matter using my name and the 5 who recced me. What you couldn"t do was update that to the 24 who recced my post. It was noticed by all that the whole contrived thread was removed by Admin first thing in the morning. That is not quiet debating.
There have been many great posts on the subject for a while now. Like anybody else there is nothing more I would love than to receive a blockbuster RNS updating us to the early potential of Moditope. I just feel Scancell will not issue one on the basis of one patient. Over the years we have discussed so many times the merits of stories about new wonder cancer drugs involving 2/3 patients and it just didn"t see credible. I hope I am wrong and we have more data to share with credibility .
#Again just my opinion the ridiculous demeaning posts directed at a few as to whether they are here for the science or money was as a distraction posted all day. Surely the two go together, if the patients are not showing remarkable signs of recovery then talk of £8 or £12 are pointless. Todays posts again are interesting as to our expectations and hopes, which is why I am just trying to contain my excitement as to what could be.
TF, after all these years I look forward to your opinion not you being judge and jury to every post posted. Is that a lot to ask for?
As ever really looking forward to next week, and after a week where we saw a retrace which IMHO was hardly not expected I felt Friday was really interesting. We opened .60 down and on the lowest volume all week we finished plus 3.33%.
Just hoping that will continue to next week and we meet these targets whether they be 30p, 36p or more, and as important to achieving the targets we have to pray that the patients respond, lives are saved and the war against cancer one day can be won. Surely that is what matters TF, not building little armies to rec you.
Have a good weekend all.
Oh dear indeed, is there any point in constantly referring to Patient x or whoever WW is. As it happens last week I wasn"t aware another "patient" had been asking questions, but surely discussing who is genuine or not is just a personal opinion, at this stage impossible to prove and therefore pointless.
It only IMHO takes away from the many RNSs we have received in the past few weeks. I was just surprised and very disappointed that the news had very little impact on the share price, and it made me feel what do we need to get some blue days apart from the obvious firm data. Even the commercial deal, from memory fizzled out quickly, mainly due IMHO to ot actually knowing how much the deal comprised off.
But moving on from McMillans BB we have heard about partial response and recruitment at last is coming our way, which is a direct result of oncologists discussing Scancell and Moditope. Recruitment has been difficult for us and so many other sall bios as it is the oncogist who recommends a suitable trial to a specific patient and as word gets out about issues like partial response news like in most things moves fast among the industry, removes large elements of risk, no oncologist wants there name associated with a trial that takes lives quicker than they save them.#
I just feel we have more to discuss than that BB and the general concensus here for a long time has been our Market Cap bears scant regard to where we are now. With that in mind and a few RNSs that have "grown on me" who is to say that the best part of our doubling in share price is a matter of re rate, I am hardly a disciple of Zak Mir but he and there are many amongst us still feel after doubling we have a long way north to go and there are many avenues of news which could easily propel us to achieve that.
As ever time only will tell, but I am pretty sure with the quality of posters here that what we are seeing and being told in RNSs is of great interest, exciting, bodes well for our future rather than the constant debating of who is genuine, or not, on a BB we had never really heard of until very recently.
Have a good weekend all
Just wanted to add to my 10.52, and where I thought violindog was hitting on, that I have had no experience of being a trial patient. My experiences are based only on dangerous levels of radiation, which takes many months to see conclusive results, and also which we believe is why I am here today on cryoblation treatments which also take over 6 months to see conclusive results as the area, in this case the lung suffers high levels of bruising. Until that settles down no scans can detect whether the tumour has been destroyed.
It is entirely IMHO that those patients who are deemed appropiate for surgery and chemotherapy and immunotherapy treatments will be told exactly what the most recent scans reveal immediately, simply because the mental well being of the patient is so important in fighting the treatment and the situation they are in.
I think we all realise the importance of Scancell having conclusive evidence from at least a handful of patients before releasing such price sensitive news.
But we do know what partial response means. Again purely IMHO such an observation will travel like wildfire through the Oncology industry, and it is very possible that is the reason why recruitment has been stepped up as indeed so will dosages. I still don"t understand what we need to do to gain Breakthrough Therapy status and perhaps anybody who knows better can add to that.To this day I am sograteful for the treatment given to me for 9 years. I know deep inside that had I not have been transferred from The Royal Free where I was diagnosed , to UCLH I wouldn"t be here now. That is no slight on The Royal Free but the treatments available at the UCLH are possibly only equalled in this country as ther new unit/building for Immunotherapy suggests.